1.11
+0(+0.00%)
Currency In USD
| Previous Close | 1.11 |
| Open | 1.14 |
| Day High | 1.14 |
| Day Low | 1.11 |
| 52-Week High | 2.67 |
| 52-Week Low | 0.9 |
| Volume | 46,753 |
| Average Volume | 108,800 |
| Market Cap | 11.38M |
| PE | -1.19 |
| EPS | -0.93 |
| Moving Average 50 Days | 1.03 |
| Moving Average 200 Days | 1.35 |
| Change | 0 |
If you invested $1000 in Cocrystal Pharma, Inc. (COCP) 10 years ago, it would be worth $5.51 as of January 19, 2026 at a share price of $1.11. Whereas If you bought $1000 worth of Cocrystal Pharma, Inc. (COCP) shares 5 years ago, it would be worth $42.24 as of January 19, 2026 at a share price of $1.11.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus
GlobeNewswire Inc.
Dec 18, 2025 1:00 PM GMT
Subject enrollment expected to begin in Q1 2026CDI-988 is the first oral broad-spectrum antiviral drug candidate for potential prevention of norovirus outbreaks and treatment of acute viral gastroenteritis caused by norovirus infectionThere are no ap
Cocrystal Pharma to Present at the Noble Capital Markets’ 21st Emerging Growth Equity Conference
GlobeNewswire Inc.
Dec 01, 2025 1:00 PM GMT
BOTHELL, Wash., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that James Martin, CFO and co-CEO, will present a Company overview and clinical progress update at NobleCon 21 – Noble
Cocrystal Pharma Insiders Purchase $1.03 Million in Private Placement Priced At-the-Market Under Nasdaq Rules
GlobeNewswire Inc.
Oct 30, 2025 12:00 PM GMT
Investment by Directors and Management demonstrates confidence in the Company Potential for an additional $1.8 million upon the exercise in full of warrants BOTHELL, Wash., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (th